Hot Features
Premium
Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Período:
Tipo de Línea:
| Volume | 4,237,056 |
|
|||||
| Noticias | (5) | ||||||
| Máximo del Dia | 1,739.50 | Mínimo Máximo |
|||||
| Minimo del Dia | 1,724.50 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Gsk Plc | GSK | London | Acción Ordinaria |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 5.00 | 0.29% | 1,733.50 | 10:35:18 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 1,733.00 | 1,724.50 | 1,739.50 | 1,733.50 | 1,728.50 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 8,703 | 4,237,056 | 1,732.36p | 73,400,966p | - | 1,302.60 - 1,739.50 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 10:49:22 | O | 185 | 1,733.50p | GBX |
| Sector Industrial de la empresa |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Información Financiera Gsk Plc GSK
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 71.35B | 4.12B | - | 30.33B | 4.93B | 1.20 | 14.48 |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Gsk Plc GSK
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 03/5/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 01/5/2024 | 09:00 | RNS Regulatory News | GSK PLC Total Voting Rights |
| 01/5/2024 | 02:50 | Alliance News |  TOP NEWS: GSK expects momentum to continue after strong.. |
| 01/5/2024 | 01:00 | RNS Regulatory News | GSK PLC 1st Quarter Results |
| 24/4/2024 | 03:14 | Alliance News | GSK's Jemperli with chemotherapy accepted for priority.. |
| 24/4/2024 | 01:00 | RNS Regulatory News | GSK PLC US FDA accepts new indication filing for Jemperli |
| 19/4/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 17/4/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 17/4/2024 | 02:46 | Alliance News | TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea.. |
| 17/4/2024 | 01:05 | RNS Regulatory News | GSK PLC GSK announces additional EAGLE-1 results |
| 17/4/2024 | 01:00 | RNS Regulatory News | GSK PLC Results from long-term data relating to Shingrix |
| 16/4/2024 | 08:11 | RNS Regulatory News | GSK PLC Amendment - Director/PDMR Shareholding |
Histórico de Datos GSK
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,638.50 | 1,739.50 | 1,634.00 | 1,688.60 | 5,724,166 | 95.00 | 5.80% |
| 1 Month | 1,612.00 | 1,739.50 | 1,575.00 | 1,638.19 | 5,986,230 | 121.50 | 7.54% |
| 3 Months | 1,658.60 | 1,739.50 | 1,575.00 | 1,661.12 | 7,825,029 | 74.90 | 4.52% |
| 6 Months | 1,399.40 | 1,739.50 | 1,379.60 | 1,574.42 | 7,697,356 | 334.10 | 23.87% |
| 1 Year | 1,457.40 | 1,739.50 | 1,302.60 | 1,497.83 | 7,423,588 | 276.10 | 18.94% |
| 3 Years | 1,338.00 | 1,824.40 | 1,283.20 | 1,512.07 | 8,570,252 | 395.50 | 29.56% |
| 5 Years | 1,555.20 | 1,857.00 | 1,190.80 | 1,525.05 | 8,871,058 | 178.30 | 11.46% |
